in determining carcinogenic risk for complex mixtures of The present study determined tumorigenicity, tumor classichemicals such as MGP. This has led investigators to employ fication and DNA damage induced in infant mice by relatively high doses of single agents to establish monocausal
benzo[a]pyrene (B[a]P) or Manufactured Gas Plant (MGP)
relative risk. The potential increment, however, in cancer residues after a single exposure. Male and female B 6 C 3 F 1 risk due to exposure to low and varied doses of individual mice were exposed to B[a]P or MGP residue from a single carcinogens in complex mixtures may far exceed expected environmental site (MGP-4) and males were also exposed risk determined by summation of potencies of individual to MGP residue composite from seven different sites (MGPcarcinogens in mixtures. Identification of interaction patterns M7). At 26, 39 and 52 weeks after exposure tumorigenesis between specific types of chemicals in mixtures and consistency was assessed in lung, forestomach and liver. Formation of patterns is required for chemical regulation, their hazard and persistence of DNA adducts were quantified by 32 mixtures of PAH such as MGP residues (8-10). The nature in males and females. Adducts in liver, lung and forestomand extent of tumor outcomes for MGP residue have therefore ach peaked on different days and decreased at different been inferred from the known tumorigenic properties of specific rates. At 24 h post-exposure, no significant differences in PAHs. Most of these studies involved skin painting in mice initial DNA adduct levels occurred in males and females using an initiation/promotion protocol. It is uncertain how to exposed to MGP-4 or B[a]P. Lack of DNA damage use these data to assess risk to human health due to MGP (adducted DNA) did not account for non-responsiveness of residues (11-14). In the absence of other data, the US EPA lung and forestomach in B 6 C 3 F 1 genders as well as in liver has suggested an approach wherein the potency of a complex in females. MGP tumorigenicity could not be accounted mixture of PAH, i.e. MGP, is derived from summing contribufor solely by B[a]P content nor did it reflect additivity of tions of the mixture's known carcinogens (15).
B[a]P and other carcinogenic polycyclic aromatic hydrocar-
We have conducted studies comparing tumor outcomes bons (PAHs) in MGP. Synergy among MGP-PAHs, presence after exposure with B[a]P and MGP residues. Previously we of unidentified carcinogens and/or promoters in MGP may analyzed both spontaneous and chemically induced tumors account for MGP potency. The B 6 C 3 F 1 infant male model in mice (16,17) using a modified protocol based on that is a convenient and rapid assay for assessing MGP liver characterized by Vesselinovitch, which exploits heightened tumorigenicity and potency.
susceptibility of infant mice to tumorigenesis in target tissues resulting from a single exposure to carcinogens including B[a]P (18-26). Unlike chronic feeding protocols, which can Introduction take 2 years or more to complete, the modified infant mouse Gas produced from the destructive distillation of coal was protocol results in significant tumor incidence in target tissues used in residential and industrial applications for over 100 as early as 26 weeks post-exposure. The present study utilized a single exposure by intraperitoneal (i.p.) injection of MGP Liver weights at 26 weeks post-exposure expressed as In males liver weight averaged 5.80 Ϯ 0.57 in the 375 B[a]P dose group, 5.63 Ϯ 0.59 in the MGP-4 7980 µg group, while corn oil exposed males averaged 5.22 Ϯ 0.67. These findings induced tumors at 52 weeks post-exposure as well as classification of all liver tumors at all doses and time points. were significant to a P value Ͼ0.001. Similar relationships between B[a]P, MGP and corn oil exposed females were also DNA adducts found at 26 weeks post-exposure (data not presented). Liver
Formation and persistence of DNA adducts in liver, lung and weights also increased at later time points in higher dose forestomach in mice exposed to 375 µg B[a]P and various groups, a finding that correlated with tumor burden in males.
doses of MGP residues are presented in Figure 5 and summarClassification of liver tumors ized in Tables IIIϪV. Liver DNA adducts were maximal 24 h post-exposure and decreased significantly during the next 14 Striking differences were evident in the phenotypic distributions of tumors induced by B[a]P or MGPs. Most B[a]P days. In contrast, maximal DNA adduct levels in the forestomach were observed 2-3 days after exposure to B[a]P or MGP; induced tumors scored as type I (Figure 1) , with some type II ( Figure 2 ) and a few type III (Figure 3) tumors. MGP induced adduct levels then decreased significantly by 14 days. The relative levels and persistence of lung DNA adducts were liver tumors were rarely type I, mostly types II and III with a few type IV (Figure 4) evident. These distributions of tumor highly variable during the initial 14-day observation period. For B[a]P, maximal lung DNA adducts were observed 3 days types were observed for each dose group and time point. (Table VI) . In contemporaneous studies, initial adduct levels (per 10 7 normal nucleotides) at day 1 after exposure to 7980 µg MGP-4 in male and female B 6 C 3 F 1 livers were not significantly different (4.89 Ϯ 0.53 in males and 4.60 Ϯ 1.4 in females), nor were they different in males and females given 375 µg B[a]P (2.40 Ϯ 0.66 compared to 2.33 Ϯ 0.74). DNA adducts detected in lung and forestomach were also comparable for both sexes (data not shown). and insolubility at higher doses in corn oil vehicle did not permit MGP exposure doses to be performed at levels at which B[a]P tumorigenesis was assessed. In pilot studies using DMSO as vehicle, the MTD for MGP-4 was only 665 µg, an exposure in which B[a]P content was 1.04 µg. At this dose MGP-4 was not carcinogenic while tumorigenesis response to DMSOϪB[a]P doses were similar to those reported in Table  I with corn oil vehicle (data not presented). The experiments summarized in Tables IϪVI utilized higher exposure. In fact MGPs induced liver tumors, depending on the residue and dosage, with incidence ranging from 3-14% at 26 weeks post-exposure, a time two-thirds of that required for the approximate 10ϫ B[a]P dose to induce tumorigenesis. Based on chemical analyses of MGP-4 and MGP-M7 and calculated potencies for their carcinogenic PAHs (37) liver tumorigenesis response did not reflect additivity of individual PAHs carcinogenicity in MGP. In both MGP residues B[a]P represented at least 60-70% of the overall carcinogenic potency of the identified hydrocarbons (39, 40) . These results suggest that tumorigenicity of MGP residues may be related to the presence of other unidentified carcinogenic PAHs in MGP, trace amounts of as yet unidentified potent carcinogens or synergistic interactions between B[a]P and other components (including PAHs) in MGP (40) .
This latter interpretation is supported by histologic analysis of the induced liver tumors. In his original study, Becker (27) noted that types I and II tumors were usually seen in spontan- chemically-induced tumors. Since B 6 C 3 F 1 male mice can exhibit spontaneous liver tumor incidence rates ranging from 10 to 76% by 2 years of age (41) having a more malignant phenotype that mechanistically may takes advantage of the heightened susceptibility of 12-15 day-old mice to induction of hepatocarcinogenesis by single reflect synergism of MGP chemical constituents. Becker (28) suggested that this phenomenon might be due to the population exposure to a carcinogen. Development of this infant mouse model resulted from a series of studies directed at determining of initiated cells that are 'hit' by carcinogen and genetic predisposition of those cells to progress towards malignancy.
sensitivity, in general, of the mouse bioassay system and particularly response of liver to various known carcinogens While previous studies indicate B [a] P is the dominant carcinogenic PAH in MGP-4 (43), other constituents (alkyl-substituted (26, 44, 45) . The advantage of using the infant mouse in hepatocarcinogenesis studies was demonstrated when dosage PAHs) in MGP may be carcinogenic. Previous analysis of MGP-4 for contamination by trace levels of 2,3,7,8-tetrachloroof 15-day-old B 6 C 3 F 1 males receiving non-toxic dose levels of carcinogen induced a spectrum of well defined liver predibenzo-p-dioxin (TCDD), a potent murine liver carcinogen, and related compounds was negative (38) . malignant changes and hepatocellular carcinomas by 40 weeks post-exposure while single 10ϫ doses of the same carcinogen The tumorigenesis protocol utilized in the present study at 42-days-of-age failed to induce lesions within 2-years postmassive cell division (23,25). High cellular replication has been viewed as enhancing base mispairing and error prone exposure. This short susceptibility window represents a time in mouse infancy in which the liver is actively undergoing repair at a time, as in this model, when carcinogen is present then leading to fixation of the primary biochemical lesion(s) important in evaluating results of a single carcinogenesis protocol. Weyand and Wu (59) also used 32 P-postlabeling (46) . We confirmed this cell division window in a previous study in which transient high levels of bromodeoxyuridine combined with multidimensional thin-layer chromatography and reverse phase high-pressure liquid chromatography to uptake were observed in livers of infant B 6 C 3 F 1 mice after a single exposure to B[a]P or MGP residues (47) . In the present analyze DNA adducts induced in female A/J mice following ingestion of MGP residues or B[a]P. In mice fed MGP, two study liver weight data demonstrated liver growth in each treatment group at 26 weeks post-exposure in both males and major adducts detected in lung appeared to be derived from benzo [b] fluoranthene and B[a]P, whereas a third major adduct females, a finding not supporting inhibition of liver growth at this time point in females (26 weeks post-exposure) as could not be attributed to any PAH identified as a MGP constituent. Detection of this major unknown adduct enhances mechanistic in tumorigenesis resistance.
In general, inbred laboratory mouse strains vary in their the plausibility that unknown PAHs or PAH-like compounds contribute to the high carcinogenicity potency of MGP. susceptibilities to spontaneous and chemically induced carcinogenesis (48) and in particular to hepatocarcinogenesis Failure to observe extrahepatic tumors in male mice and induce tumors in females at any site could be due to several (49) (50) (51) . For example, C 3 H mice are much more susceptible to both spontaneous and chemically induced liver tumors than factors including organ-and sex-dependent differences in induction of DNA damage by MGPϪPAHs. The 32 P-postla-C57BL/6, A/J and SWR/J mice. Further, in most mouse strains utilized to study liver tumor induction, almost invariably males beling assay was used to determine levels and persistence of covalent DNA adducts in both male and female B 6 C 3 F 1 mice exhibit higher incidence, higher multiplicity and/or shortened latent period in generation of hepatic tumors than females of treated with B[a]P (375 µg/mouse), MGP-4 (7980 µg) and MGP-M7 (7980, 3990 or 1995 µg/mouse) residues ( Figure 5 , the same strain. The C57 ϫ C 3 H hybrid strain B 6 C 3 F 1 utilized in this study exhibits high natural liver tumor incidence (52) Tables IIIϪV). In liver in male B 6 C 3 F 1 mice, 24 h after administration of B[a]P or MGP residues, RAL values were characterizing C 3 H males and modifying influence of gender on tumor incidence. Ovariectomy of female B 6 C 3 F 1 mice 3.41, 4.30 and 1.39 per 10 7 nucleotides for B[a]P, MGP-4 and MGP-M7 respectively at doses of 375, 7980 and 7980 µg/ increases both spontaneous and chemically initiated liver tumor incidence while castration reduces male liver tumor incidence mouse. The differences in RAL values observed after 24 h were not apparent after 14 days. Thus in an organ susceptible down to that of females (53) . In the present study nonresponsiveness, at any known PAH target site, in B 6 C 3 F 1 may to chemical-induced tumorigenesis, levels of DNA adducts induced by B[a]P and MGPϪPAH mixtures were different (2-reflect hormonal suppression of promotion and progression during multistage carcinogenesis in females through 52 weeks to 3-fold) at only early time points post-treatment. In a separate study, hepatic DNA adduct levels were determined in both post-exposure (54) (55) (56) (57) (58) . Lack of induction of lung and forestomach tumors in males may represent a lengthened latent period male and female mice treated with MGP-4 residue (7980 µg) and B[a]P (375 µg) ( Table VI) . The results showed no for these target organs. In this regard, in a study appearing in 1975, Vesselinovitch et al. (26) reported that when 15-day-old significant differences in RAL values in male or female mice 1, 14 or 28 days after administration of PAHs. Thus both B 6 C 3 F 1 males and females were exposed to a single dose of 525 or 1050 µg B[a]P the average age at which liver tumors MGP-4 and B[a]P induced DNA adducts in male and female B 6 C 3 F 1 mice whereas liver tumors were induced only in males. were observed ranged from 93-81 weeks for males and 116-90 weeks for females. Vesselinovitch's study utilized B 6 C 3 F 1
In general liver carcinogenesis resistance and/or latency in female B 6 C 3 F 1 mice reflect differences in promotion and produced from C57BL/6J ϫ C 3 HeB/FeJ and trioctanoin as vehicle, which complicates direct comparison with the present progression of initiated liver cells in females (26, 53, 58) compared with B 6 C 3 F 1 males. study. However, in that study (26) females exposed to B[a]P on day 15 of age exhibited only 7% liver tumor induction at Results summarizd in Tables IIIϪVI also show that after exposure of male and female B 6 C 3 F 1 to B[a]P or MGPs DNA 116 and 90 weeks at B[a]P doses of 525 and 1050 µg respectively, with no spontaneous liver tumors at the 90 week adduct levels in lung and forestomach on their respective peak days were significantly higher than those observed in liver. time point. Regardless, then, of which C57 and C 3 H substrains were used as progenitors, their F1 female hybrids are Adducts were higher and more persistent in lung than in liver or forestomach, a finding consistent with slower cell turnover resistant to PAH (26) and MGP induced liver carcinogenesis. Vesselinovitch et al. (26) also reported significant incidences in lung and forestomach and/or differences in initial adduction of DNA and adduct persistence in the differing cell types of lung and forestomach tumors in B 6 C 3 F 1 genders at times ranging from 77-122 weeks post-exposure to B[a]P doses.
comprising liver, lung and forestomach. These results indicate that B[a]P and MGP residues induce DNA damage in liver, Only 22 lung tumors sporadically induced within the four bioassays performed and no forestomach tumors were seen in forestomach and lung with failure to induce forestomach and lung tumorigenesis, the result of either failure to proceed the present study. Based on the differential in potency of B[a]P related to MGPs demonstrated in the present study and DNA through subsequent stages in multistage carcinogenesis after initiation or tumorigenesis latency of greater than 1 year postdamage detected in all three target organs, lack of significant tumor induction in lung and forestomach does not appear to exposure (26) . Further, these studies indicate that adduction of DNA in lung and forestomach in both B 6 C 3 F 1 males and simply reflect shorter duration of the present experiment (26) but more likely differences in the genetic make-up of females and additionally in liver in females is in itself not sufficient to induce tumors. This was particularly striking since progenitors used to breed F1 mice. Weyand et al. (10) demonstrated that ingestion of MGP in males lung and forestomach exhibited much higher initial DNA adduct levels, which in the case of lung exhibited much residues by female A/J mice produced only lung tumors, whereas feeding or a single i.p. injection of B[a]P induced higher and longer persistence than liver. In a recently completed infant mouse carcinogenicity assay both lung and forestomach tumors. Therefore, consideration of both route of administration as well as mouse strain is in which we exposed male B 6 C 3 F 1 to a 'reconstituted mix'
